Literature DB >> 21817817

How to treat stage D heart failure? - When to implant left ventricular assist devices in the era of continuous flow pumps?-.

Koichiro Kinugawa1.   

Abstract

The new classification of heart failure in the American College of Cardiology/American Heart Association guidelines includes stage D, which is refractory severe heart failure that does not respond to medical or resynchronization therapy. Among the many treatment strategies for stage D heart failure, only heart transplantation and ventricular assist devices have been established as improving prognosis. With the evolution in the mechanics of ventricular assist devices in recent years, the postoperative prognosis has improved, and less sick patients can now be candidates for these devices. In Japan, 2 continuous flow devices have been approved since April 2011, and now is the best time to consider the indications for their use.

Entities:  

Mesh：

Year:  2011        PMID： 21817817     DOI： 10.1253/circj.cj-11-0621

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


  10 in total

1.  Early decision for a left ventricular assist device implantation is necessary for patients with modifier A.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Yasushi Imai; Atsushi Yao; Yasunobu Hirata; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-04-18       Impact factor: 1.731

2.  How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Naoko Kato; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Atsushi Yao; Yasunobu Hirata; Masaaki Akahane; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-07-17       Impact factor: 1.731

3.  Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Masaru Hatano; Takeo Fujino; Hironori Muraoka; Toshiro Inaba; Hisataka Maki; Yukie Kagami; Miyoko Endo; Osamu Kinoshita; Kan Nawata; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2013-12-15       Impact factor: 1.731

4.  High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2015-09-22       Impact factor: 1.731

5.  Biventricular failure with low pulmonary vascular resistance was managed by left ventricular assist device alone without right-sided mechanical support.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Masaru Hatano; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2015-03-13       Impact factor: 1.731

6.  Preoperative iodine-123 meta-iodobenzylguanidine imaging is a novel predictor of left ventricular reverse remodeling during treatment with a left ventricular assist device.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2015-07-29       Impact factor: 1.731

7.  Is cardiopulmonary exercise testing essential to indicate ventricular assist device implantation in patients with INTERMACS profile 4-7?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2016-03-18       Impact factor: 1.731

8.  Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Masaru Hatano; Naoko Kato; Shun Minatsuki; Hironori Muraoka; Toshiro Inaba; Hisataka Maki; Mitsutoshi Kimura; Osamu Kinoshita; Taro Shiga; Atsushi Yao; Shunei Kyo; Minoru Ono; Issei Komuro
Journal:  J Artif Organs       Date:  2013-04-05       Impact factor: 1.731

9.  Improved clinical course of autologous skeletal myoblast sheet (TCD-51073) transplantation when compared to a propensity score-matched cardiac resynchronization therapy population.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Yasushi Sakata; Shigeru Miyagawa; Yoshiki Sawa; Kenji Yamazaki; Minoru Ono
Journal:  J Artif Organs       Date:  2015-08-13       Impact factor: 1.731

Review 10.  Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support.

Authors:  Teruhiko Imamura; Nikhil Narang
Journal:  Medicina (Kaunas)       Date:  2020-08-15       Impact factor: 2.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.